(ii) Micro-organisms The following organisms were tested: 64 strains of C difficile (including NCTC 11207 and NCTC 11209), three strains of C sordellii (including NCTC 8780), three strains of C bifermentans (including NCTC 6801 and NCTC 6927), three strains of C sporogenes (including NCTC 6929), three strains of C perfringens, one strain of C butyricum, two strains of C septicum, one strain of C tertium, one strain of C novyi, 15 strains of Bacteroides sp, four strains of anaerobic streptococci, 14 strains of faecal streptococci, four strains of Salmonella sp, one strain of Shigella sp, four strains ofYersinia enterocolitica and 24 strains of other enterobacteriaceae.
Clostridium difficile is the causal agent of most cases of pseudomembranous colitis' and is frequently linked with many incidents of antibiotic associated diarrhoea.2" In these instances confirmation that C difficile is the infecting agent is made by detection of the specific cytotoxin or enterotoxin and isolation of the organism. Most laboratories use cycloserine (500 mg/l), cefoxitin (16 mg/l) fructose agar (CCFA) for culture,5 or the subsequent modification containing half the concentration of antibiotics. 8 Irrespective of antibiotic concentration, the selectivity of the medium is relatively poor and, the use of alcohol shock on the sample before it is plated out is recommended. 9 The medium also orginally included egg yolk which has more recently been replaced by 7% (v/v) whole horse blood. This report presents the results of a comparison of CCFA with a new selective medium (CDMN) that uses the same basal agar as CCFA, but incorporates cysteine hydrochloride as a growth supplement, and norfloxacin and moxalactam as selective agents, in the direct culture offaeces for the isolation of C difficile. (ii) Micro-organisms The following organisms were tested: 64 strains of C difficile (including NCTC 11207 and NCTC 11209), three strains of C sordellii (including NCTC 8780), three strains of C bifermentans (including NCTC 6801 and NCTC 6927), three strains of C sporogenes (including NCTC 6929), three strains of C perfringens, one strain of C butyricum, two strains of C septicum, one strain of C tertium, one strain of C novyi, 15 strains of Bacteroides sp, four strains of anaerobic streptococci, 14 strains of faecal streptococci, four strains of Salmonella sp, one strain of Shigella sp, four strains ofYersinia enterocolitica and 24 strains of other enterobacteriaceae.
Isolates (other than NCTC strains) were obtained from clinical specimens. The MIC for each strain was determined against norfloxacin, but against moxalacatam, only isolates of Clostridium sp and Bacteroides sp were examined. (iii) Media MICs were performed using two basal media. Freshly prepared C difficile and DST agar containing doubling dilutions of norfloxacin (4 mg/1-512 mg/l) and moxalactam (0.0625 mg/1-256 mg/l) were used for MIC determinations, together with control plates containing no antibiotics. All isolates for testing were incubated overnight aerobically in New selective medium for isolating C difficile from faeces 20 ml volumes of fastidious anaerobe broth (FAB) (Lab M) at 37°G before diluting the cultures with fresh FAB until a turbidity was reached roughly equivalent to 106-107 organisms/ml (previously assessed). Diluted broths (20 pul) were then inoculated on to each of the test media using a Ledwell multipoint applicator (LEEC Ltd, Nottingham, England).
All plates were incubated in an anaerobic atmosphere at 37°C for 48 hours.
The MICs of the strains were recorded as the lowest dilution of antibiotic required to inhibit fully growth of the organism. Variation in colonial morphology was also recorded.
STUDY OF FAECAL SPECIMENS
Using a sterile swab, 832 fresh faecal specimens from patients with diarrhoea were directly inoculated on to:
(i) Clostridium difficile base (with 0.5 g/l of cysteine hydrochloride and 7% blood) containing 12 mg/l of norfloxacin and 32 mg/l of moxalactam (CDMN).
(ii) Clostridium difficile base with 500 mg/l of cycloserine and 16 mg/l of cefoxitin (C difficile selective supplement, Unipath Ltd) (CCFA).
The plates were then spread four times using a sterile loop and incubated anaerobically at 37°C for 48 hours.
All suspect colonies of C difficile were presumptively identified using the C difficile microscreen latex test (Mercia Diagnostics Ltd, Guildford, England) with all positive isolates being confirmed using API ZYM (API bioMerieux Ltd, Basingstoke, England).'°"
Growth was assessed semiquantitatively for the isolation of (i) C difficile and (ii) all colonies other than C difficile-contaminants. This was achieved by designating a growth value of between 1 and 5 according to the amount of growth obtained. Growth in the primary inoculation only being given a value of 1, growth extending into the primary streaks, 2, growth into the secondary streaks, 3, and so on up to a growth value of 5.
Results

MIC DETERMINATIONS
The MICs of norfloxacin and moxalactam against all isolates tested were similar on C difficile agar base and DST agar base. Table 1 shows the MICs for norfloxacin against 64 strains of C difficile and 83 other bacteria, and To ensure that neither antibiotic, either alone or in combination, affected the colonial morphology of C difficile, 64 strains were studied. Six isolates were slightly affected at 16 mg/l of norfloxacin, yet remained unaffected at 12 mg/l. The colonial morphology then remained similar to that on control plates (no antibiotics) when 12 mgIl of norfloxacin was combined with 32 mg/l of moxalactam (CDMN) agar. Cysteine hydrochloride (05 g/l) was also included in the medium as this was not only shown to increase greatly the growth rate of C difficile in brain heart infusion broth (Unipath Ltd), but also significantly to improve the Chatreuse green fluorescence of the colonies under long wave ultraviolet (366 nm) light (unpublished data).
The CDMN medium was 20% more effective in its isolation rate than in CCFA. The possibility that the 24 additional isolates obtained using the CDMN medium were sensitive to the antibiotics present in the CCFA was investigated by subculturing all 24 strains on to CCFA. All strains grew after 48 hours of anaerobic incubation. One explanation for this is that on primary isolation, the antibiotics present in CCFA were too inhibitory for potentially stressed organisms. On subculture, these were then able to tolerate the antibiotics. The more likely explanation is that the large (33%) reduction in the growth of contaminating organisms on the CDMN medium facilitated recognition of lower numbers of C difficile colonies within the faecal culture. This view was supported by the increase in total growth values for isolates of C difficile from 408 to 462 on CDMN medium.
The study therefore concludes that C difficile base with 0 5 g/l of cysteine hydrochloride, 7% whole horse blood, 12 mg/l of norfloxacin and 32 mg/l of moxalactam is a more sensitive medium supplement for direct culture and isolation of C difficile from faeces than the present commercially available cycloserine cefoxitin fructose agar.
